Collectin 11 在小鼠类风湿关节炎模型中的保护作用
研究利用胶原诱导性关节炎(CIA)小鼠模型,结合Colec11基因敲除与重组CL-11治疗两种方法,发现CL-11通过抑制抗原提呈细胞活化及后续T细胞反应减轻关节炎。RA患者血清CL-11水平低于健康对照,且与疾病活动度呈负相关。
要点
- Colec11缺失小鼠CIA病情更重,伴APC活化、Th1/Th17反应及致病性IgG2a增强。
- 重组CL-11治疗可减轻小鼠CIA严重程度。
- RA患者血清CL-11低于健康对照,且与DAS28、ESR、CRP负相关。
核心结论
- CL-11在CIA小鼠模型中发挥保护作用,机制涉及抑制APC活化及后续T细胞反应。
研究设计与样本
- 采用小鼠胶原诱导性关节炎(CIA)模型,结合Colec11基因敲除与重组CL-11治疗两种方法。
- 评估关节炎症与组织破坏、循环炎性细胞因子水平及适应性免疫应答。
- 用脾脏CD11c+细胞体外分析CL-11对抗原提呈细胞功能的影响。
- 检测RA患者(n=51)与健康对照(n=53)血清CL-11水平。
主要发现
- Colec11-/-小鼠较野生型小鼠关节炎更严重,依据发病率、临床关节炎评分和组织病理学判定(P < 0.05)。
- 疾病严重程度与APC活化、Th1/Th17反应、致病性IgG2a产生、关节炎症及循环炎性细胞因子升高显著相关。
- 体外CD11c+细胞分析显示CL-11对抑制APC活化与功能至关重要。
- 重组CL-11药物治疗降低小鼠CIA严重程度。
- RA患者血清CL-11水平低于健康对照,且降低与28关节疾病活动度评分、红细胞沉降率和C反应蛋白水平呈负相关(P < 0.05)。
临床怎么用
- CL-11可能作为RA疾病活动度的潜在血清标志物,其水平降低与DAS28、ESR、CRP负相关。
- 重组CL-11在小鼠CIA中显示治疗潜力,提示靶向CL-11通路可能为RA治疗方向。
局限性
- 机制结论主要基于小鼠CIA模型及体外CD11c+细胞分析,人体因果作用未验证。
- RA患者血清CL-11分析为横断面比较,样本量有限(RA n=51,对照 n=53)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Collectin 11 (CL-11) is a soluble C-type lectin, a mediator of innate immunity. Its role in autoimmune disorders is unknown. We undertook this study to determine the role of CL-11 in a mouse model of rheumatoid arthritis (RA). METHODS: A murine collagen-induced arthritis (CIA) model was used and combined two approaches, including gene deletion of Colec11 and treatment with recombinant CL-11 (rCL-11). Joint inflammation and tissue destruction, circulating levels of inflammatory cytokines, and adaptive immune responses were assessed in mice with CIA. Splenic CD11c+ cells were used to examine the influence of CL-11 on antigen-presenting cell (APC) function. Serum CL-11 levels in RA patients were also examined. RESULTS: Colec11-/- mice developed more severe arthritis than wild-type mice, as determined by disease incidence, clinical arthritis scores, and histopathology (P < 0.05). Disease severity was associated with significantly enhanced APC activation, Th1/Th17 responses, pathogenic IgG2a production and joint inflammation, as well as elevated circulating levels of inflammatory cytokines. In vitro analysis of CD11c+ cells revealed that CL-11 is critical for suppression of APC activation and function. Pharmacologic treatment of mice with rCL-11 reduced the severity of CIA in mice. Analysis of human blood samples revealed that serum CL-11 levels were lower in RA patients (n = 51) compared to healthy controls (n = 53). Reduction in serum CL-11 was inversely associated with the Disease Activity Score in 28 joints, erythrocyte sedimentation rate, and C-reactive protein level (P < 0.05). CONCLUSION: Our findings demonstrate a novel role of CL-11 in protection against RA, suggesting that the underlying mechanism involves suppression of APC activation and subsequent T cell responses.
引用
- Wang N, Wu W, Qiang C, et al. Protective Role of Collectin 11 in a Mouse Model of Rheumatoid Arthritis. Arthritis Rheumatol. 2021. PMID: 33605085. doi:10.1002/art.41696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。